AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Each Tablet Contains: Etoricoxib 120,0 Mg in South Africa

9 products registered with SAHPRA — 9 active

Brand / ProductReg. No.HolderStatusExpires
BRUTASULT 12057/3.1/0815Evohealth (Pty) Ltdactive23 Jun 2031
EXTRIB 120 mg50/3.1/0237Pharma Dynamics (Pty) Ltdactive29 May 2031
ETORICOXIB 120 BIOTECH50/3.1/0588Biotech Laboratories (Pty) Ltdactive17 Mar 2031
AZCURA 12047/3.1/0548Zydus Healthcare (Pty) Ltdactive19 Jan 2031
ETORICOXIB ZYDUS 12047/3.1/0551Zydus Healthcare (Pty) Ltdactive19 Jan 2031
ETIFLAM 12050/3.1/0818.815Cipla Medpro (Pty) Ltdactive14 Jan 2031
THRYTIX 12050/3.1/0645Ranbaxy (SA) (Pty) Ltdactive5 Dec 2030
EBOV 12051/3.1/0907Activo Health (Pty) Ltdactive17 Nov 2030
ECOXAR 12051/3.1/1147Ranbaxy Pharmaceutical (Pty) Ltdactive2 Nov 2025

Each Tablet Contains: Etoricoxib 120,0 Mg — SAHPRA Registration Details

SAHPRA (South Africa) has 9 registered products containing Each Tablet Contains: Etoricoxib 120,0 Mg, of which 9 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Each Tablet Contains: Etoricoxib 120,0 Mg registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.